Table IV.
Parameter | Hazard ratio (95% confidence interval) |
P value |
---|---|---|
At Complete Remission (N=260) | ||
| ||
Age | 1.023 (1.011, 1.036) | 0.0002 |
WBC | 1.002 (1.000, 1.004) | 0.04 |
Cytogenetics | 0.85 (0.57, 1.25) | 0.40 |
MRD at CR | 1.4 (0.94, 2.10) | 0.1 |
| ||
At 3 Months from Therapy Initiation (N=216) | ||
| ||
Age | 1.023 (1.010, 1.036) | 0.0004 |
WBC | 1.002 (1.000, 1.004) | 0.04 |
Cytogenetics | 0.87 (0.59, 1.28) | 0.47 |
MRD at 3 Months | 1.96 (0.85, 4.50) | 0.12 |
| ||
At 6 Months from Therapy Initiation (N=166) | ||
| ||
Age | 1.022 (1.010, 1.035) | 0.0005 |
WBC | 1.001 (1.000, 1.003) | 0.12 |
Cytogenetics | 0.92 (0.63, 1.35) | 0.67 |
MRD at 6 Months | 2.68 (0.89, 8.06) | 0.08 |
WBC, white blood cell count; MRD, minimal residual disease; CR, complete remission